The European League Against Rheumatism (EULAR) has revised its recommendations for managing fibromyalgia, updating them based on evidence from systematic reviews and meta-analyses. The new guidelines emphasize the importance of prompt diagnosis, patient education, and a comprehensive assessment of pain, function, and psychosocial context. The management approach is structured as a graduated program, prioritizing non-pharmacological therapies over pharmacological ones. Exercise is strongly recommended due to its effectiveness in reducing pain, improving physical function, and well-being. Other non-pharmacological therapies, such as acupuncture, cognitive behavioral therapy, and hydrotherapy, are also supported based on moderate evidence. Pharmacological treatments, including antidepressants, anticonvulsants, and opioids, are weakly recommended or strongly discouraged due to limited efficacy or safety concerns. The guidelines also highlight the need for individualized treatment plans and the importance of addressing comorbidities. Research priorities include identifying effective exercise types, combining pharmacological and non-pharmacological approaches, and optimizing healthcare systems to improve outcomes.The European League Against Rheumatism (EULAR) has revised its recommendations for managing fibromyalgia, updating them based on evidence from systematic reviews and meta-analyses. The new guidelines emphasize the importance of prompt diagnosis, patient education, and a comprehensive assessment of pain, function, and psychosocial context. The management approach is structured as a graduated program, prioritizing non-pharmacological therapies over pharmacological ones. Exercise is strongly recommended due to its effectiveness in reducing pain, improving physical function, and well-being. Other non-pharmacological therapies, such as acupuncture, cognitive behavioral therapy, and hydrotherapy, are also supported based on moderate evidence. Pharmacological treatments, including antidepressants, anticonvulsants, and opioids, are weakly recommended or strongly discouraged due to limited efficacy or safety concerns. The guidelines also highlight the need for individualized treatment plans and the importance of addressing comorbidities. Research priorities include identifying effective exercise types, combining pharmacological and non-pharmacological approaches, and optimizing healthcare systems to improve outcomes.